Education
About Us
Working with TipRanks
Follow Us
Kane Biotech Inc (TSE:KNE)
:KNE
KNE Stock Chart & Stats
C$0.03
<C$0.01(4.76%)
At close: 4:00 PM EST
C$0.03
<C$0.01(4.76%)
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.13
Previous CloseN/A
Volume199.87K
Average Volume (3M)112.95K
Market Cap
C$4.99M
Enterprise ValueC$9.13M
Total Cash (Recent Filing)C$1.61M
Total Debt (Recent Filing)C$2.61M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding166,233,230
10 Day Avg. Volume120,057
30 Day Avg. Volume112,955
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-9.04
Price to Sales (P/S)7.08
P/FCF Ratio-3.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kane Biotech News
KNE FAQ
What was Kane Biotech Inc’s price range in the past 12 months?
Kane Biotech Inc lowest stock price was C$0.03 and its highest was C$0.13 in the past 12 months.
What is Kane Biotech Inc’s market cap?
Kane Biotech Inc’s market cap is C$4.99M.
When is Kane Biotech Inc’s upcoming earnings report date?
Kane Biotech Inc’s upcoming earnings report date is Nov 27, 2025 which is today.
How were Kane Biotech Inc’s earnings last quarter?
Currently, no data Available
Is Kane Biotech Inc overvalued?
According to Wall Street analysts Kane Biotech Inc’s price is currently Overvalued.
Does Kane Biotech Inc pay dividends?
Kane Biotech Inc does not currently pay dividends.
What is Kane Biotech Inc’s EPS estimate?
Kane Biotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kane Biotech Inc have?
Kane Biotech Inc has 166,233,230 shares outstanding.
What happened to Kane Biotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kane Biotech Inc?
Currently, no hedge funds are holding shares in TSE:KNE
Company Description
Kane Biotech Inc
Kane Biotech (KNE) is a biotechnology company focused on the development of innovative antimicrobial technologies aimed at addressing biofilm-related challenges across various sectors, including healthcare, veterinary, and industrial applications. The company specializes in creating patented products designed to prevent and treat biofilm infections, which are significant contributors to chronic infections and device-related complications. Kane Biotech's core products include wound care solutions and antimicrobial coatings that enhance the efficacy of medical devices.
Technical Analysis
Hemostemix
―
Britannia Life Sciences Inc
―
Resverlogix
―
Sirona Biochem
―
BetterLife Pharma
―
Options Prices
Currently, No data available
---